Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.330
+0.190 (8.88%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Perspective Therapeutics Stock Forecast
CATX's stock price has decreased by -84.71% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Perspective Therapeutics stock have an average target of 13.89, with a low estimate of 6.00 and a high estimate of 22. The average target predicts an increase of 496.14% from the current stock price of 2.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 4 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $10 | Strong Buy | Maintains | $21 → $10 | +329.18% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +329.18% | Mar 31, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +543.78% | Mar 27, 2025 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +372.10% | Mar 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +329.18% | Mar 19, 2025 |
Financial Forecast
Revenue This Year
751.13K
from 1.45M
Decreased by -48.34%
Revenue Next Year
759.78K
from 751.13K
Increased by 1.15%
EPS This Year
-1.26
from -1.23
EPS Next Year
-1.56
from -1.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.5M | 2.5M | 88.5M | ||
| Avg | 751,128 | 759,778 | 14.7M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 71.9% | 235.5% | 11,550.1% | ||
| Avg | -48.3% | 1.2% | 1,832.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.04 | -1.07 | -2.02 | ||
| Avg | -1.26 | -1.56 | -1.96 | ||
| Low | -1.81 | -2.02 | -1.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.